Jean‐Charles Nault

机构：Délégation Paris 5, Inserm, Université Paris Cité, Sorbonne Université, Université Sorbonne Paris Nord, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Assistance Publique – Hôpitaux de Paris, Hôpital Avicenne · ORCID：0000-0002-4875-9353

发表论文 352 篇 · 总被引 18142 次 · h-index 61

代表论文

• Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 52)
• Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy (2025 · Liver International · 被引 7)
• Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinoma (2025 · Cell Reports Medicine · 被引 7)
• Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study (2025 · Hepatology International · 被引 5)
• LBA51 IKF-035/ABC-HCC: A phase IIIb, randomized, multicenter, open-label trial of atezolizumab plus bevacizumab versus transarterial chemoembolization (TACE) in intermediate-stage hepatocellular carcinoma (2025 · Annals of Oncology · 被引 4)
• Early Hemostatic Treatment Could Improve 30‐Day Survival After Spontaneous Rupture of Hepatocellular Carcinoma (2025 · Liver International · 被引 3)